Santen Pharmaceutical Co., Ltd.
SNPHF News Today: Stay Updated with the Latest Santen Pharmaceutical Co., Ltd. News in Real Time
Find SNPHF news now at Meyka AI. Stay informed with the latest Santen Pharmaceutical Co., Ltd. stocks updates, including price news, market analysis, and expert insights.

POET Stock Crashes 50% as Marvell Technology Partnership Falls Apart
POET Stock saw a sharp and sudden fall, dropping nearly 50 percent in a single session after news broke that its partnership with Marvell Technology had collapsed. The development has shocked investors, as the deal was seen as a key growth driver for POET Technologies in the high-speed optical and semiconductor space. The company had…

COUR.PA Stock Flat at €116 in Pre-Market, April 28 2026
COUR.PA stock holds €116 in pre-market trading. Real estate firm shows mixed signals with negative earnings and oversold conditions on EURONEXT.

XBAC.SW Volume Spike 262% Above Average on 28 Apr 2026
XBAC.SW trading volume surges 262% above average at CHF 15.18 on SIX. ESG bond ETF shows unusual activity in pre-market session.

3930.T Stock Plunges 21.7% on JPX: Hatena Co. Faces Sharp Intraday Decline
Hatena Co. (3930.T) drops 21.7% intraday on JPX. Stock falls to ¥925 from ¥1,181 close. Market analysis and trading activity.

SpaceX Falcon Heavy April 28: First Launch in 18 Months
SpaceX Falcon Heavy launches April 29 with ViaSat-3 F3 satellite, marking its first mission in 18 months for commercial space communications.

KG.SW Kinross Gold Earnings Preview April 29
Kinross Gold (KG.SW) reports Q1 2026 earnings April 29. Analysts expect $0.5680 EPS and $1.90B revenue. Gold prices and production key.

CGN Power 1816.HK Gains 2.65% on Earnings Spotlight, 28 Apr 2026
CGN Power 1816.HK rises 2.65% to HK$3.48 on earnings announcement. Nuclear power leader trades at 15.82 PE on HKSE.

DBK.SW Deutsche Bank Earnings Preview April 29
Deutsche Bank earnings preview for April 29, 2026. EPS estimate $0.8810, revenue estimate $7.87B. What to watch.

TR9.DE Stock Bounces Back: OTRS AG Oversold Recovery on XETRA
OTRS AG (TR9.DE) shows oversold bounce potential at €17.55 on XETRA. Meyka AI rates B grade with HOLD recommendation.